Table 2.
Laboratory test results for COVID-19 patients and healthy controls
| COVID-19 | Healthy controls | Healthy controls versus COVID-19 patients (p) |
Regular wards versus Specialized wards (p) |
|||
|---|---|---|---|---|---|---|
| Regular wards | Specialized wards | Total | ||||
| N = 40 | N = 20 | N = 60 | N = 86 | |||
| Covid-positive, verified | 40 (100%) | 20 (100%) | 60 (100%) | |||
| D-dimer, mg/L, median (IQR) | 0.6 (0.5–1.0) | 1.5 (0.7–4.0) | 0.7 (0.5–1.5) | 0.002 | ||
| Hemoglobin, g/L, median (IQR) | 137 (125–148) | 123 (110–128) | 129 (120–141) | 141 (134–150) | <0.001 | <0.001 |
| Platelet count, 109/L, median (IQR) | 212 (175–259) | 252 (206–341) | 221 (181–287) | 257 (229–283) | 0.005 | 0.094 |
| APTT, sec, median (IQR) | 26 (24–27) | 26 (25–30) | 26 (24–29) | 33 (31–36) | <0.001 | 0.891 |
| INR, median (IQR) | 1.0 (1.0–1.1) | 1.0 (1.0–1.1) | 1 (1–1.1) | 1.0 (1.0–1.1) | 0.107 | 0.843 |
| P-fibrinogen, g/L, median (IQR) | 5.4 (4.3–6.5) | 6.8 (4.8–7.6) | 5.7 (4.3–6.9) | 2.7 (2.4–3.0) | <0.001 | 0.125 |
| Antithrombin, kIE/L, median (IQR) | 1.0 (0.9–1.1) | 1.0 (0.9–1.1) | 1.0 (0.9–1.1) | 0.836 | ||
| EXTEM-CT, sec, median (IQR) | 70 (61–75) | 90 (78–108) | 74 (64–90) | 47 (43–51) | <0.001 | <0.001 |
| EXTEM-CFT, sec, median (IQR) | 49 (44–63) | 46 (42–55) | 49 (43–63) | 91 (79–101) | <0.001 | 0.485 |
| EXTEM-A5, mm, median (IQR) | 51 (47–54) | 57 (54–60) | 53 (48–58) | 0.009 | ||
| EXTEM-A10, mm, median (IQR) | 61 (57–65) | 68 (63–70) | 63 (59–68) | 0.006 | ||
| EXTEM-MCF, mm, median (IQR) | 70 (66–73) | 76 (71–77) | 71 (68–75) | 64 (62–68) | <0.001 | 0.009 |
| EXTEM-LI30, %, median (IQR) | 100 (100–100) | 100 (100–100) | 100 (100–100) | 0.632 | ||
| INTEM-CT, sec, median (IQR) | 190 (173–202) | 183 (175–195) | 187 (173–202) | 163 (157–170) | <0.001 | 0.588 |
| INTEM-CFT, sec, median (IQR) | 60 (50–73) | 46 (40–-59) | 56 (45–71) | 63 (57–72) | 0.001 | 0.041 |
| INTEM-A5, mm, median (IQR) | 47 (42–51) | 54 (49–59) | 49 (45–54) | 0.014 | ||
| INTEM-A10, mm, median (IQR) | 58 (54–61) | 64 (60–68) | 60 (55–64) | 0.010 | ||
| INTEM-MCF, mm, median (IQR) | 67 (63–69) | 72 (68–75) | 67 (64–72) | 66 (64–69) | 0.050 | 0.006 |
| INTEM-LI30, %, median (IQR) | 100 (100–100) | 100 (100–100) | 100 (100–100) | 1.000 | ||
| FIBTEM-MCF, mm, median (IQR) | 27 (23–31) | 32 (28–36) | 29 (24–33) | 13 (11–15) | <0.001 | 0.036 |
| HEPTEM-CT, sec, median (IQR) | 188 (180–203) | 179 (173–191) | 182 (175–199) | 0.089 | ||
IQR interquartile range, APTT activated partial thromboplastin time, INR international normalized ratio